SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-051914
Filing Date
2008-08-11
Accepted
2008-08-11 16:50:09
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-19101_110q.htm 10-Q 1044602
2 EX-10.2 a08-19101_1ex10d2.htm EX-10.2 130908
3 EX-31.1 a08-19101_1ex31d1.htm EX-31.1 19217
4 EX-31.2 a08-19101_1ex31d2.htm EX-31.2 19446
5 EX-32.1 a08-19101_1ex32d1.htm EX-32.1 9683
  Complete submission text file 0001104659-08-051914.txt   1225345
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 081006944
SIC: 2835 In Vitro & In Vivo Diagnostic Substances